Read a report of the ANZCA Council meeting held on 2-3 November in person.

The Faculty of Pain Medicine says there needs to be more clinical evidence about the efficacy of medicinal cannabis before use as a treatment for chronic, non-cancer pain.

You can now enjoy all six stories from our popular ANZCA Bulletin series 'Beyond City Limits' as an ebook.

The Western Australian Therapeutic Advisory Group and the Western Australian Drug Evaluation Panel have endorsed the delisting of Desflurane from the WA Statewide Medicines Formulary.

In the latest episode of our audio series, ANZCA President Dr Chris Cokis interviews fellow ANZCA Council colleague Professor Leonie Watterson.

Following the celebrations at the FPM Spring Meeting, we've launched a new online exhibition.

Registrations for the 2024 ANZCA ASM and FPM Symposium are now open!

Updates include: PPRN webinar; Foundation supporter evening; 2024 research grants; global health challenges

Dr Min-Qi Lee knows all too well the impact of the postcode lottery of health on patients living in regional, rural and remote areas.

FPM committees support the board in achieving its objectives in the training, examination and continuing education of specialist pain medicine physicians and in setting the standards of clinical practice for pain medicine in Australia and New Zealand.